What Are The Threadlike Proteins That Attach To Platelets?

Platelet Levels. The number of platelets in the blood varies between 150-350 x109 / L. Platelets The main function of platelets is a responsibility in the formation of blood clots during hemostasis. Xa can be activated by plasma FV FXa while remaining attached to the surface of the cell, bearing...Fibrin is a protein that acts as a first response whenever your body is injured in order to play an important role in the blood clotting process. As a result, this mesh stops the blood by capturing red blood cells, leukocytes and platelets, generating a clot and forming a kind of tampon at the injured...Answer: A blood clot consists of a mesh of fibrin threads, clumped platelets, and trapped red blood cells. More specifically, they are glycoproteins—proteins with attached carbohydrate. Question: What are two mechanisms by which blood clots are prevented from propagating back through the...High platelets is a condition in which the blood contains more platelets than normal. In a healthy person, there are usually 150,000 to 450,000 platelets per microliter of blood. What is high platelets?Blood clotting or blood coagulation: Platelets along with other clotting factors perform or carry out the function of blood coagulation. Defense mechanism: Platelets defense mechanism is the ability of platelets to carry out Protein-energy Malnutrition - Overview, Symptoms, Prevention and More.

What are the threadlike proteins that attach to platelets in blood...

How Blood Clots Hemostasis is the body's way of stopping injured blood vessels from bleeding. The platelets change shape from round to spiny, and they release proteins and other substances that entrap more platelets and clotting proteins in the enlarging plug that becomes a blood clot.As the blood clots, how do white blood cells prevent bacteria on the glass from infecting her blood? They bring more oxygen to the site for repair. What are the threadlike proteins that attach to platelets in blood clotting? coagulant thrombocytes hemoglobin fibrin.blood disease: Diseases related to platelets and coagulation proteins. Bleeding disorders may result from inherited or acquired defects of clotting Mammalian platelets are nonnucleate cells produced by large bone marrow cells called megakaryocytes and circulate in the blood in a resting, inactive...Platelets, also called thrombocytes (from Greek θρόμβος, "clot" and κύτος, "cell"), are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot.

How Blood Clots: Platelets and the Coagulation Cascade

Blood clots are the result of a clotting mechanism. The fibrin moves to the area that the platelets have sealed. Strands of fibrin attach themselves over the platelets to strengthen and stabilize the clot. The clotting mechanism varies slightly depending on the type of blood vessel in which the...Platelets, also known as thrombocytes, are blood cells responsible for blood clotting. If a blood vessel wall becomes damaged, platelets will The specific lab markers that refer to platelets are as follows: Platelet Count (PLT). Just as it sounds, this is the actual number of platelets you have (per...Platelets circulate in the blood and are involved in hemostasis, leading to the formation of blood clots and If the number of platelets in the blood is too low, excessive bleeding can occur. Platelets also contain adhesive proteins that allow them to adhere to fibrin mesh and the vascular endothelium...Clotting in the abdomen (splanchnic vein thrombosis) has also been detected among some recipients of the vaccine, according to the EMA. The MHRA said there had been 79 cases of CVST associated with low platelet cells in the blood. These conditions emerged after administration of the first dose.Platelets are small cell fragments in your blood that help form blood clots. A platelet count totals your platelets to help screen for or diagnose bleeding or clotting A platelet count is used to determine the number of platelets in your blood. The test is included in a complete blood count (CBC), a panel...

Jump to navigation Jump to search PlateletsSymbol from a gentle microscope (500 ×) from a Giemsa-stained peripheral blood smear showing platelets (crimson dots) surrounded by crimson blood cells (pink round constructions)Main pointsPrecursorMegakaryocytesFunctionFormation of blood clots; prevention of bleedingIdentifiersLatinThrombocytesMeSHD001792FMA62851Anatomical terms of microanatomy

Platelets, also called thrombocytes (from Greek θρόμβος, "clot" and κύτος, "cell"), are a component of blood whose serve as (along with the coagulation elements) is to react to bleeding from blood vessel harm by way of clumping, thereby starting up a blood clot.[1] Platelets have no mobile nucleus; they are fragments of cytoplasm that are derived from the megakaryocytes[2] of the bone marrow, which then input the circulate. Circulating unactivated platelets are biconvex discoid (lens-shaped) constructions,[3][4]:117–18 2–3 µm in greatest diameter.[5] Activated platelets have mobile membrane projections covering their surface. Platelets are discovered handiest in mammals, while in other vertebrates (e.g. birds, amphibians), thrombocytes circulate as intact mononuclear cells.[4]:3

The ligands, denoted by letter L, sign for platelets (P) to migrate in opposition to the wound (Site A). As more platelets collect around the opening, they produce extra ligands to amplify the reaction. The platelets congregate round the wound in order to create a cap to forestall blood float out of the tissue.

On a stained blood smear, platelets seem as dark pink spots, about 20% the diameter of crimson blood cells. The smear is used to read about platelets for length, form, qualitative number, and clumping. A wholesome grownup normally has 10 to 20 times more crimson blood cells than platelets. One primary serve as of platelets is to contribute to hemostasis: the process of preventing bleeding at the website of interrupted endothelium. They gather at the website and, unless the interruption is physically too huge, they plug the hole. First, platelets attach to substances outdoor the interrupted endothelium: adhesion. Second, they change shape, turn on receptors and secrete chemical messengers: activation. Third, they attach to each other through receptor bridges: aggregation.[6] Formation of this platelet plug (number one hemostasis) is related to activation of the coagulation cascade, with resultant fibrin deposition and linking (secondary hemostasis). These processes would possibly overlap: the spectrum is from a predominantly platelet plug, or "white clot" to a predominantly fibrin, or "red clot" or the more typical mixture. Some would upload the next retraction and platelet inhibition as fourth and 5th steps to the crowning glory of the process[7] and nonetheless others would upload a sixth step, wound repair. Platelets also take part in both innate[8] and adaptive[9] intravascular immune responses. The platelet cellular membrane has receptors for collagen. Following the rupture of the blood vessel wall, the platelets are exposed and so they adhere to the collagen in the surrounding connective tissue.

Low platelet concentration is known as thrombocytopenia, and is due to both lowered production or higher destruction. Elevated platelet concentration is called thrombocytosis, and is either congenital, reactive (to cytokines), or due to unregulated manufacturing: one in all the myeloproliferative neoplasms or positive different myeloid neoplasms. A disorder of platelet function is a thrombocytopathy.

Normal platelets can reply to an abnormality on the vessel wall moderately than to hemorrhage, resulting in inappropriate platelet adhesion/activation and thrombosis: the formation of a clot within an intact vessel. This form of thrombosis arises by way of mechanisms other from those of a normal clot: namely, extending the fibrin of venous thrombosis; extending an risky or ruptured arterial plaque, inflicting arterial thrombosis; and microcirculatory thrombosis. An arterial thrombus may in part hinder blood glide, causing downstream ischemia, or may completely impede it, causing downstream tissue death.

Measurement

Platelet concentration is measured either manually using a hemocytometer, or by means of hanging blood in an automated platelet analyzer the use of electric impedance, reminiscent of a Coulter counter.[10] The standard range (99% of inhabitants analyzed) for platelets in wholesome Caucasians is 150,000 to 450,000 consistent with cubic millimeter [11](a mm3 equals a microliter). or 150–450 × 109 in keeping with liter. The standard range has been showed to be the same in the aged[12] and Spanish populations.[13]

The collection of platelets varies throughout folks. The standard physiologic vary is 200,000 to 500,000 according to microliter of blood. Since they include receptors for thrombopoietin (the protein that facilitates the maturation of megakaryocytes and liberate of platelets), the next choice of platelets binds more of the protein. Consequently, there may be stimulation for more manufacturing of thrombopoietin in the liver and kidneys. This is the basis for the manufacturing of more thrombopoietin and, as a result, more platelets in the bloodstream all the way through the blood clotting process.

Shape

In a first approximation, the platelet form can be regarded as equivalent to oblate spheroids, with a semiaxis ratio of two to 8.[14] This approximation is steadily used to type the hydrodynamic and optical properties of a platelet population, as well as to restore the geometric parameters of particular person measured platelets through go with the flow cytometry.[15] More correct biophysical fashions of the platelet floor morphology, which style its form from first rules, make it imaginable to obtain a more practical platelet geometry in a calm and activated state.[16]

Structure

Structurally the platelet can also be divided into 4 zones, from peripheral to innermost:

Peripheral zone – is wealthy in glycoproteins required for platelet adhesion, activation and aggregation. For example, GPIb/IX/V; GPVI; GPIIb/IIIa. Sol-gel zone – is wealthy in microtubules and microfilaments, permitting the platelets to deal with their discoid shape. Organelle zone – is rich in platelet granules. Alpha granules include clotting mediators equivalent to aspect V, ingredient VIII, fibrinogen, fibronectin, platelet-derived expansion factor, and chemotactic agents. Delta granules, or dense our bodies, contain ADP, calcium and serotonin, which are platelet-activating mediators. Membranous zone – incorporates membranes derived from megakaryocytic smooth endoplasmic reticulum arranged right into a dense tubular machine which is chargeable for thromboxane A2 synthesis. This dense tubular machine is connected to the floor platelet membrane to assist thromboxane A2 release.

Development

Platelets derive from totipotent marrow stem cells Megakaryocyte and platelet manufacturing is regulated by thrombopoietin, a hormone produced in the kidneys and liver. Each megakaryocyte produces between 1,000 and 3,000 platelets throughout its lifetime. An reasonable of 1011 platelets are produced daily in a wholesome adult. Reserve platelets are saved in the spleen, and are released when wanted by way of splenic contraction caused by way of the sympathetic nervous system. Platelets extruded from megakaryocytes The average existence span of circulating platelets is 8 to Nine days.[17] Life span of particular person platelets is controlled through the inner apoptotic regulating pathway, which has a Bcl-xL timer.[18] Old platelets are destroyed via phagocytosis in the spleen and liver.

Hemostasis

3-D rendering of four inactivated and three activated platelets.

An evaluate summarizing platelet dynamics, the complicated technique of changing inactive platelets right into a platelet plug, is essential. Complicating any verbal description is the truth that at least 193 proteins and 301 interactions are involved in platelet dynamics. The separation of platelet dynamics into three levels turns out to be useful in this regard, however it's artificial: in reality, each stage is initiated in speedy succession, and each and every continues until the trigger for that stage is not present, so there may be overlap.[6]

Adhesion

Thrombus formation on an intact endothelium is avoided by means of nitric oxide,[19]prostacyclin,[20] and CD39.[21]

Endothelial cells are attached to the subendothelial collagen by von Willebrand aspect (VWF), which those cells produce. VWF may be saved in the Weibel-Palade our bodies of the endothelial cells and secreted constitutively into the blood. Platelets retailer vWF in their alpha granules.

When the endothelial layer is disrupted, collagen and VWF anchor platelets to the subendothelium. Platelet GP1b-IX-V receptor binds with VWF; and GPVI receptor and integrin α2β1 bind with collagen.[22]

Activation Scanning electron micrograph of blood cells. From left to correct: human erythrocyte, activated platelet, leukocyte. Inhibition

The intact endothelial lining inhibits platelet activation by way of generating nitric oxide, endothelial-ADPase, and PGI2 (prostacyclin). Endothelial-ADPase degrades the platelet activator ADP.

Resting platelets take care of active calcium efflux by means of a cyclic AMP-activated calcium pump. Intracellular calcium concentration determines platelet activation standing, as it's the 2d messenger that drives platelet conformational alternate and degranulation (see underneath). Endothelial prostacyclin binds to prostanoid receptors on the floor of resting platelets. This event stimulates the coupled Gs protein to building up adenylate cyclase task and will increase the production of cAMP, further selling the efflux of calcium and lowering intracellular calcium availability for platelet activation.

ADP on the different hand binds to purinergic receptors on the platelet surface. Since the thrombocytic purinergic receptor P2Y12 is coupled to Gi proteins, ADP reduces platelet adenylate cyclase job and cAMP manufacturing, main to accumulation of calcium inside of the platelet by inactivating the cAMP calcium efflux pump. The different ADP-receptor P2Y1 couples to Gq that turns on phospholipase C-beta 2 (PLCB2), ensuing in inositol 1,4,5-trisphosphate (IP3) era and intracellular unencumber of extra calcium. This together induces platelet activation. Endothelial ADPase degrades ADP and prevents this from going down. Clopidogrel and related antiplatelet drugs also work as purinergic receptor P2Y12 antagonists.

Trigger (induction)

Platelet activation begins seconds after adhesion happens. It is triggered when collagen from the subendothelium binds with its receptors (GPVI receptor and integrin α2β1) on the platelet. GPVI is associated with the Fc receptor gamma chain and leads by the use of the activation of a tyrosine kinase cascade after all to the activation of PLC-gamma2 (PLCG2) and more calcium liberate.

Tissue component additionally binds to ingredient VII in the blood, which initiates the extrinsic coagulation cascade to increase thrombin production. Thrombin is a potent platelet activator, appearing through Gq and G12. These are G protein coupled receptors and they activate calcium-mediated signaling pathways inside the platelet, overcoming the baseline calcium efflux. Families of 3 G proteins (Gq, Gi, G12) perform in combination for complete activation. Thrombin additionally promotes secondary fibrin-reinforcement of the platelet plug. Platelet activation in turn degranulates and releases factor V and fibrinogen, potentiating the coagulation cascade. So, in truth, the strategy of platelet plugging and coagulation are happening concurrently quite than sequentially, with each and every inducing the other to shape the final fibrin-crosslinked thrombus.

Components (consequences) GPIIb/IIIa activation

Collagen-mediated GPVI signalling increases the platelet production of thromboxane A2 (TXA2) and reduces the manufacturing of prostacyclin. This happens by altering the metabolic flux of platelet's eicosanoid synthesis pathway, which involves enzymes phospholipase A2, cyclo-oxygenase 1, and thromboxane-A synthase. Platelets secrete thromboxane A2, which acts on the platelet's personal thromboxane receptors on the platelet surface (hence the so-called "out-in" mechanism), and the ones of different platelets. These receptors cause intraplatelet signaling, which converts GPIIb/IIIa receptors to their active form to begin aggregation.[6]

Granule secretion Diagram of the structure of a platelet appearing the granules

Platelets include dense granules, lambda granules and alpha granules. Activated platelets secrete the contents of those granules through their canalicular programs to the exterior. Simplistically, certain and activated platelets degranulate to release platelet chemotactic brokers to attract extra platelets to the website online of endothelial harm. Granule characteristics:

α granules (alpha granules) – containing P-selectin, platelet element 4, transforming growth factor-β1, platelet-derived enlargement aspect, fibronectin, B-thromboglobulin, vWF, fibrinogen, and coagulation factors V and XIII δ granules (delta or dense granules) – containing ADP or ATP, calcium, and serotonin γ granules (gamma granules) – identical to lysosomes and comprise a number of hydrolytic enzymes λ granules (lambda granules) – contents involved in resorption all through later phases of vessel repairMorphology alternate

As shown by way of flow cytometry and electron microscopy, the maximum sensitive signal of activation, when uncovered to platelets the use of ADP, are morphological changes.[23] Mitochondrial hyperpolarization is a key event in initiating changes in morphology.[24] Intraplatelet calcium concentration increases, stimulating the interaction between the microtubule/actin filament complex. The steady adjustments in form from the unactivated to the totally activated platelet is highest seen on scanning electron microscopy. Three steps along this path are named early dendritic, early unfold and spread. The surface of the unactivated platelet appears very equivalent to the floor of the brain, with a wrinkled look from numerous shallow folds to increase the floor house; early dendritic, an octopus with more than one arms and legs; early unfold, an uncooked frying egg in a pan, the "yolk" being the central physique; and the unfold, a cooked fried egg with a denser central body.

These changes are all brought about via the interaction of the microtubule/actin complicated with the platelet cellular membrane and open canalicular system (OCS), which is an extension and invagination of that membrane. This complex runs simply beneath these membranes and is the chemical motor which accurately pulls the invaginated OCS out of the interior of the platelet, like turning pants pockets within out, growing the dendrites. This procedure is identical to the mechanism of contraction in a muscle cell.[25] The complete OCS thus turns into indistinguishable from the preliminary platelet membrane as it bureaucracy the "fried egg". This dramatic build up in surface space comes about with neither stretching nor including phospholipids to the platelet membrane.[26]

Platelet-coagulation component interactions: coagulation facilitation

Platelet activation reasons its membrane surface to develop into negatively charged. One of the signaling pathways turns on scramblase, which moves negatively charged phospholipids from the inner to the outer platelet membrane floor. These phospholipids then bind the tenase and prothrombinase complexes, two of the sites of interaction between platelets and the coagulation cascade. Calcium ions are crucial for the binding of those coagulation components.

In addition to interacting with vWF and fibrin, platelets have interaction with thrombin, Factors X, Va, VIIa, XI, IX, and prothrombin to complete formation by means of the coagulation cascade.[27][28] Six research urged platelets express tissue ingredient: the definitive learn about displays they don't.[27] The platelets from rats had been conclusively proven to specific tissue component protein and likewise it was once proved that the rat platelets raise each the tissue aspect pre-mRNA and mature mRNA.[29]

Aggregation Platelet clumps in a blood smear

Aggregation begins minutes after activation, and occurs on account of turning on the GPIIb/IIIa receptor, permitting these receptors to bind with vWF or fibrinogen.[6] There are round 60,000 of these receptors consistent with platelet.[30] When any a number of of a minimum of 9 different platelet surface receptors are turned on all through activation, intraplatelet signaling pathways purpose existing GpIIb/IIIa receptors to alternate shape – curled to immediately – and thus turn out to be in a position to binding.[6]

Since fibrinogen is a rod-like protein with nodules on both end capable of binding GPIIb/IIIa, activated platelets with uncovered GPIIb/IIIa can bind fibrinogen to aggregate. GPIIb/IIIa might also further anchor the platelets to subendothelial vWF for additional structural stabilisation.

Classically it used to be thought that this was once the only mechanism involved in aggregation, but 3 new mechanisms had been identified which is able to initiate aggregation, relying on the speed of blood waft (i.e. shear vary).[31]

Wound repair Main article: Wound restore

The blood clot is only a transient solution to prevent bleeding; tissue repair is wanted. Small interruptions in the endothelium are treated by means of physiological mechanisms; large interruptions by means of the trauma surgeon.[32] The fibrin is slowly dissolved by means of the fibrinolytic enzyme, plasmin, and the platelets are cleared by way of phagocytosis.[33]

Immune function

Platelets have central function in innate immunity, initiating and taking part in multiple inflammatory processes, immediately binding pathogens or even destroying them. This supports scientific knowledge which show that many with severe bacterial or viral infections have thrombocytopenia, thus decreasing their contribution to inflammation. Also platelet-leukocyte aggregates (PLAs) found in stream are typical in sepsis or inflammatory bowel disease, appearing the connection between thrombocytes and immune cells sensu stricto.[34]

Immunothrombosis

As hemostasis is a basic serve as of thrombocytes in mammals, it additionally has its uses in imaginable an infection confinement.[8] In case of injury, platelets, along with the coagulation cascade, form the first line of defense by forming a blood clot. Thus, hemostasis and host defense have been intertwined in evolution. For instance, in the Atlantic horseshoe crab (living fossil estimated to be over 400 million years outdated), the best blood mobile kind, the amebocyte, facilitates both the hemostatic function and the encapsulation and phagocytosis of pathogens by way of exocytosis of intracellular granules containing bactericidal protection molecules. Blood clotting helps the immune function via trapping the pathogenic bacteria inside of.[35]

Although thrombosis, blood coagulation in intact blood vessels, is in most cases viewed as a pathological immune reaction, leading to obturation of lumen of blood vessel and next hypoxic tissue injury, in some cases, directed thrombosis, called immunothrombosis, can in the community regulate the spread of the an infection. The thrombosis is directed in concordance of platelets, neutrophils and monocytes. The process is initiated both through immune cells sensu stricto via activating their development reputation receptors (PRRs), or by means of platelet-bacterial binding. Platelets can bind to micro organism both directly thru thrombocytic PRRs[34] and bacterial surface proteins, or by the use of plasma proteins that bind both to platelets and bacteria.[36] Monocytes respond to bacterial pathogen-associated molecular patterns (PAMPs), or damage-associated molecular patterns (DAMPs) via activating the extrinsic pathway of coagulation. Neutrophils facilitate the blood coagulation by way of NETosis. In flip, the platelets facilitate neutrophils' NETosis. NETs bind tissue factor, binding the coagulation centres to the location of an infection. They also activate the intrinsic coagulation pathway by way of providing its negatively charged floor to the element XII. Other neutrophil secretions, similar to proteolytic enzymes, which cleave coagulation inhibitors, also bolster the process.[8]

In case of imbalance all through the law of immunothrombosis, this procedure can briefly turn out to be aberrant. Regulatory defects in immunothrombosis are suspected to be significant factor in inflicting pathological thrombosis in many bureaucracy, equivalent to disseminated intravascular coagulation (DIC) or deep vein thrombosis. DIC in sepsis is a major example of both dysregulated coagulation procedure as well as undue systemic inflammatory response ensuing in multitude of microthrombi of equivalent composition to that in physiological immunothrombosis - fibrin, platelets, neutrophils and NETs.[8]

Inflammation

Platelets are impulsively deployed to sites of harm or infection, and potentially modulate inflammatory processes via interacting with leukocytes and via secreting cytokines, chemokines and different inflammatory mediators.[37][38][39][40][41] Platelets also secrete platelet-derived enlargement component (PDGF).

Platelets modulate neutrophils by forming platelet-leukocyte aggregates (PLAs). These formations induce upregulated production of αmβ2 (Mac-1) integrin in neutrophils. Interaction with PLAs additionally induce degranulation and larger phagocytosis in neutrophils. Platelets are also the largest source of soluble CD40L which induces manufacturing of reactive oxygen species (ROS) and upregulate expression of adhesion molecules, akin to E-selectin, ICAM-1 and VCAM-1, in neutrophils, turns on macrophages and activates cytotoxic reaction in T and B lymphocytes.[34]

Recently, the dogma that mammalian platelets lacking nucleus are not able of self reliant locomotion was once damaged.[42] In reality, the platelets are energetic scavengers, scaling partitions of blood vessels and reorganising the thrombus. They are able to acknowledge and cling to many surfaces, including bacteria. They are even in a position to fully envelop them in their open canalicular system (OCP), main to proposed identify of the procedure being "covercytosis", reasonably than phagocytosis, as OCS is simply an invagination of outer plasma membrane. These platelet-bacteria bundles are then used as an interaction platform for neutrophils which smash the bacteria using the NETosis and phagocytosis.

Platelets additionally take part in continual inflammatory sicknesses, reminiscent of synovitis or rheumatoid arthritis.[43] Platelets are activated via collagen receptor glycoprotein IV (GPVI). Proinflammatory platelet microvesicles trigger constant cytokine secretion from neighboring fibroblast-like synoviocytes, maximum prominently Il-6 and Il-8. Inflammatory injury to surrounding extracellular matrix regularly reveals extra collagen, maintaining the microvesicle production.

Adaptive immunity

Activated platelets are in a position to participate in adaptive immunity, interacting with antibodies. They are in a position to specifically bind IgG through FcγRIIA, receptor for consistent fragment (Fc) of IgG. When activated and bound to IgG opsonised micro organism, the platelets therefore unlock reactive oxygen species (ROS), antimicrobial peptides, defensins, kinocidins and proteases, killing the micro organism directly.[44] Platelets additionally secrete proinflammatory and procoagulant mediators akin to inorganic polyphosphates or platelet aspect 4 (PF4), connecting innate and adaptive immune responses.[44][45]

Signs and signs of disorders

Spontaneous and over the top bleeding can happen on account of platelet disorders. This bleeding can also be led to by means of deficient numbers of platelets, dysfunctional platelets, or very over the top numbers of platelets: over 1.0 million/microliter. (The excessive numbers create a relative von Willebrand element deficiency due to sequestration.)[46][47]

One can get a clue as to whether bleeding is due to a platelet disorder or a coagulation factor disorder through the characteristics and site of the bleeding.[4]:815, Table 39–4 All of the following suggest platelet bleeding, now not coagulation bleeding: the bleeding from a pores and skin cut similar to a razor nick is advised and excessive, but will also be controlled by means of power; spontaneous bleeding into the pores and skin which reasons a purplish stain named via its length: petechiae, purpura, ecchymoses; bleeding into mucous membranes inflicting bleeding gums, nose bleed, and gastrointestinal bleeding; menorrhagia; and intraretinal and intracranial bleeding.

Excessive numbers of platelets, and/or normal platelets responding to unusual vessel partitions, may end up in venous thrombosis and arterial thrombosis. The signs rely on the site of thrombosis.

Tests of serve as

On for instance optical densitometry, a first and 2nd wave of platelet aggregation is seen, in this situation for an ADP-initiated aggregation. Data recommend that ADP activates the PI3K/Akt pathway all the way through the first wave of aggregation, main to thrombin era and PAR‐1 activation, which inspires the 2nd wave of aggregation.[48] Bleeding time

Bleeding time was once first developed as a take a look at of platelet function by way of Duke in 1910.[49] Duke's check measured the time taken for bleeding to prevent from a standardized wound in the ear lobe which was once blotted each and every 30 seconds. The customary time for bleeding to forestall used to be less than Three minutes.[50] More trendy tactics are now used. A regular bleeding time reflects enough platelet numbers and serve as, plus standard microvasculature.

Multiple electrode aggregometry Main article: Multiple electrode aggregometry

In more than one electrode aggregometry, anticoagulated total blood is mixed with saline and a platelet agonist in a single-use cuvette with two pairs of electrodes. The build up in impedance between the electrodes as platelets mixture onto them, is measured and visualized as a curve.

Platelet aggregation serve as by means of disorders and agonists ADP Epinephrine Collagen Ristocetin P2Y receptor defect[51] (together with Clopidogrel) Decreased Normal Normal Normal Adrenergic receptor defect[51] Normal Decreased Normal Normal Collagen receptor defect[51] Normal Normal Decreased or absent Normal Von Willebrand illness[52] Bernard–Soulier syndrome[51] Normal Normal Normal Decreased or absent Glanzmann's thrombasthenia[51] Afibrinogenemia Decreased Decreased Decreased Normal or reduced Storage pool deficiency[52] Absent 2d wave Partial Aspirin or aspirin-like dysfunction Absent 2nd wave Absent Normal

Light transmission aggregometry

In light transmission aggregometry (LTA), platelet-rich plasma is placed between a mild source and a photocell. Unaggregated plasma allows fairly little light to go through. After adding an agonist, the platelets aggregate, ensuing in greater gentle transmission, which is detected by the photocell.[53]

PFA-100

The PFA-100 (Platelet Function Assay - 100) is a gadget for analysing platelet function in which citrated whole blood is aspirated thru a disposable cartridge containing an aperture within a membrane covered with either collagen and epinephrine or collagen and ADP. These agonists induce platelet adhesion, activation and aggregation, leading to speedy occlusion of the aperture and cessation of blood flow termed the closure time (CT). An elevated CT with EPI and collagen can indicate intrinsic defects reminiscent of von Willebrand disease, uremia, or circulating platelet inhibitors. The practice up test involving collagen and ADP is used to indicate if the odd CT with collagen and EPI was once brought about by means of the results of acetyl sulfosalicylic acid (aspirin) or medicines containing inhibitors.[54]

Disorders

Adapted from:[4]:vii

The three wide categories of platelet problems are "not enough"; "dysfunctional"; and "too many".[4]:vii

Thrombocytopenia Immune thrombocytopenias (ITP) – formerly known as immune thrombocytopenic purpura and idiopathic thrombocytopenic purpura Splenomegaly Gaucher's disease Familial thrombocytopenia[55] Chemotherapy Babesiosis Dengue fever Onyalai Thrombotic thrombocytopenic purpura HELLP syndrome Hemolytic–uremic syndrome Drug-induced thrombocytopenic purpura (five recognized drugs – maximum problematic is heparin-induced thrombocytopenia (HIT) Pregnancy related Neonatal alloimmune related Aplastic anemia Transfusion related Pseudothrombocytopenia idiopathic thrombocytopenic purpura Gilbert's syndrome[56]Altered platelet serve as Congenital Disorders of adhesion Bernard–Soulier syndrome Disorders of activation Disorders of granule quantity or unencumber Hermansky–Pudlak syndrome Gray platelet syndrome ADP receptor defect Decreased cyclooxygenase job Storage pool defects, bought or congenital Disorders of aggregation Glanzmann's thrombasthenia Wiskott–Aldrich syndrome Acquired Disorders of adhesion Paroxysmal nocturnal hemoglobinuria Asthma[57] Samter's triad (aspirin-exacerbated respiration illness/AERD)[58] Cancer[59] Malaria[60] Decreased cyclooxygenase activityThrombocytosis and thrombocythemia Reactive Chronic an infection Chronic irritation Malignancy Hyposplenism (post-splenectomy) Iron deficiency Acute blood loss Myeloproliferative neoplasms – platelets are each elevated and activated Essential thrombocytosis Polycythemia vera Associated with other myeloid neoplasms Congenital

Drugs affecting

Anti-inflammatory medicine

Some medication used to deal with inflammation have the undesirable aspect impact of suppressing normal platelet serve as. These are the non-steroidal anti inflammatory medicine (NSAIDS). Aspirin irreversibly disrupts platelet function through inhibiting cyclooxygenase-1 (COX1), and hence commonplace hemostasis. The ensuing platelets are not able to produce new cyclooxygenase because they have no DNA. Normal platelet serve as will not return until the use of aspirin has ceased and enough of the affected platelets had been changed by way of new ones, which will take over per week. Ibuprofen, another NSAID, does not have this type of long period impact, with platelet function normally returning inside 24 hours,[61] and taking ibuprofen earlier than aspirin prevents the irreversible results of aspirin.[62]

Drugs that suppress platelet function

These medication are used to save you thrombus formation.

Oral agents Aspirin Clopidogrel Cilostazol Ticlopidine Ticagrelor PrasugrelDrugs that stimulate platelet production Thrombopoietin mimetics Desmopressin Factor VIIaIntravenous agents Abciximab Eptifibatide Tirofiban Others: oprelvekin, romiplostim, eltrombopag, argatroban

Therapy with platelets

Transfusion Main article: Platelet transfusion Indications

Platelet transfusion is most continuously used to right kind strangely low platelet counts, either to save you spontaneous bleeding (in most cases at counts beneath 10×109/L) or in anticipation of clinical procedures that will essentially involve some bleeding. For instance, in sufferers present process surgical operation, a degree beneath 50×109/L is related to ordinary surgical bleeding, and regional anaesthetic procedures corresponding to epidurals are have shyed away from for levels beneath 80×109/L.[63] Platelets may also be transfused when the platelet depend is customary however the platelets are dysfunctional, akin to when an individual is taking aspirin or clopidogrel.[64] Finally, platelets may be transfused as a part of an enormous transfusion protocol, in which the three primary blood elements (crimson blood cells, plasma, and platelets) are transfused to deal with severe hemorrhage. Platelet transfusion is contraindicated in thrombotic thrombocytopenic purpura (TTP), as it fuels the coagulopathy.

Collection Platelet listen.

Platelets are both remoted from amassed units of whole blood and pooled to make a healing dose, or gathered by means of platelet apheresis: blood is taken from the donor, handed via a device which gets rid of the platelets, and the remainder is returned to the donor in a closed loop. The business usual is for platelets to be tested for bacteria earlier than transfusion to steer clear of septic reactions, which will also be fatal. Recently the AABB Industry Standards for Blood Banks and Transfusion Services (5.1.5.1) has allowed for use of pathogen reduction technology instead to bacterial screenings in platelets.[65]

Pooled whole-blood platelets, also known as "random" platelets, are separated through considered one of two methods.[66] In the US, a unit of total blood is placed into a big centrifuge in what is referred to as a "soft spin". At those settings, the platelets remain suspended in the plasma. The platelet-rich plasma (PRP) is got rid of from the purple cells, then centrifuged at a quicker setting to harvest the platelets from the plasma. In different regions of the global, the unit of total blood is centrifuged using settings that motive the platelets to transform suspended in the "buffy coat" layer, which contains the platelets and the white blood cells. The "buffy coat" is isolated in a sterile bag, suspended in a small amount of crimson blood cells and plasma, then centrifuged once more to separate the platelets and plasma from the pink and white blood cells. Regardless of the initial method of preparation, multiple donations is also combined into one container using a sterile connection instrument to manufacture a single product with the desired healing dose.

Apheresis platelets are gathered using a mechanical instrument that draws blood from the donor and centrifuges the accrued blood to separate out the platelets and other components to be gathered. The remaining blood is returned to the donor. The advantage to this method is that a single donation provides a minimum of one healing dose, as adversarial to the more than one donations for whole-blood platelets. This means that a recipient is not uncovered to as many alternative donors and has much less possibility of transfusion-transmitted disease and different complications. Sometimes an individual reminiscent of a most cancers affected person who requires regimen transfusions of platelets will receive repeated donations from a selected donor to additional reduce the possibility. Pathogen reduction of platelets using for example, riboflavin and UV light treatments may also be carried out to scale back the infectious load of pathogens contained in donated blood merchandise, thereby lowering the chance of transmission of transfusion transmitted diseases.[67][68] Another photochemical remedy process using amotosalen and UVA light has been developed for the inactivation of viruses, bacteria, parasites, and leukocytes that can contaminate blood components supposed for transfusion.[69] In addition, apheresis platelets tend to contain fewer contaminating pink blood cells as a result of the collection manner is more efficient than "soft spin" centrifugation at isolating the desired blood component.

Storage

Platelets gathered through either way have an excessively short shelf existence, usually 5 days. This effects in common issues of short supply, as checking out the donations continuously requires up to a full day. Since there are no efficient preservative solutions for platelets, they lose potency briefly and are very best when contemporary.

Platelets are stored under consistent agitation at 20–24 °C (68–75.2 °F). Units can not be refrigerated as this reasons platelets to exchange shape and lose function. Storage at room temperature supplies an environment where any bacteria that are presented to the blood component all through the collection process might proliferate and due to this fact reason bacteremia in the patient. Regulations are in position in the United States that require products to be tested for the presence of bacterial contamination ahead of transfusion.[70]

Platelets amassed by way of the usage of apheresis at an American Red Cross donation middle. Delivery to recipients

Platelets do not have to belong to the same A-B-O blood group as the recipient or be cross-matched to make certain immune compatibility between donor and recipient except they include a significant amount of crimson blood cells (RBCs). The presence of RBCs imparts a reddish-orange colour to the product, and is typically associated with whole-blood platelets. An effort is sometimes made to issue type particular platelets, but this isn't important as it's with RBCs.

Prior to issuing platelets to the recipient, they could also be irradiated to save you transfusion-associated graft as opposed to host disease or they may be washed to remove the plasma if indicated.

The change in the recipient's platelet depend after transfusion is termed the "increment" and is calculated by subtracting the pre-transfusion platelet rely from the post-transfusion platelet depend. Many factors affect the increment together with the recipient's body length, the selection of platelets transfused, and clinical options that might reason premature destruction of the transfused platelets. When recipients fail to demonstrate an good enough post-transfusion increment, this is termed platelet transfusion refractoriness.

Platelets, either apheresis-derived or random-donor, will also be processed through a volume relief procedure. In this process, the platelets are spun in a centrifuge and the excess plasma is removed, leaving 10 to 100 mL of platelet listen. Such volume-reduced platelets are normally transfused best to neonatal and pediatric patients, when a large quantity of plasma may overload the child's small circulatory system. The lower volume of plasma also reduces the chances of an adverse transfusion response to plasma proteins.[71] Volume lowered platelets have a shelf lifetime of simplest four hours.[72]

Wound treatment

Platelets release platelet-derived growth component (PDGF), a potent chemotactic agent; and TGF beta, which stimulates the deposition of extracellular matrix; fibroblast expansion aspect, insulin-like growth element 1, platelet-derived epidermal expansion component, and vascular endothelial expansion component. Local software of these elements in greater concentrations thru platelet-rich plasma (PRP) is used as an adjunct in wound therapeutic.[73]

Other animals

Instead of getting platelets, non-mammalian vertebrates have nucleated thrombocytes, which resemble B lymphocytes in morphology. They aggregate in reaction to thrombin, however now not to ADP, serotonin, nor adrenaline, as platelets do.[74][75]

History

George Gulliver in 1841 drew pictures of platelets[76] the usage of the dual lens (compound) microscope invented in 1830 by way of Joseph Jackson Lister.[77] This microscope stepped forward resolution sufficiently to make it conceivable to see platelets for the first time. William Addison in 1842 drew pictures of a platelet-fibrin clot.[78] Lionel Beale in 1864 was once the first to submit a drawing appearing platelets.[79] Max Schultze in 1865 described what he referred to as "spherules", which he noted have been a lot smaller than pink blood cells, from time to time clumped, and were infrequently found in collections of fibrin material.[80] Giulio Bizzozero in 1882 studied the blood of amphibians microscopically in vivo. He named Schultze's spherules (It.) piastrine: little plates.[81][82] William Osler seen platelets and, in published lectures in 1886, called them a third corpuscle and a blood plaque; and described them as "a colorless protoplasmic disc".[83] James Wright examined blood smears the usage of the stain named for him, and used the time period plates in his 1906 newsletter[84] but modified to platelets in his 1910 publication[85] which has become the universally authorised term.

The time period thrombocyte (clot cellular) got here into use in the early 1900s and is now and again used as a synonym for platelet; but no longer in most cases in the scientific literature, excluding as a root phrase for other phrases similar to platelets (e.g. thrombocytopenia which means low platelets).[4]:v3 The time period thrombocytes is right kind for mononuclear cells found in the blood of non-mammalian vertebrates: they are the functional similar of platelets, but flow into as intact cells fairly than cytoplasmic fragments of bone marrow megakaryocytes.[4]:3

In some contexts, the word thrombus is used interchangeably with the word clot, irrespective of its composition (white, purple, or mixed). In different contexts it is used to contrast a typical from an bizarre clot: thrombus arises from physiologic hemostasis, thrombosis arises from a pathologic and over the top quantity of clot.[86] In a 3rd context it's used to distinction the outcome from the procedure: thrombus is the result, thrombosis is the process.

References

^ .mw-parser-output cite.quotationfont-style:inherit.mw-parser-output .quotation qquotes:"\"""\"""'""'".mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free abackground:linear-gradient(clear,clear),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .quotation .cs1-lock-limited a,.mw-parser-output .quotation .cs1-lock-registration abackground:linear-gradient(transparent,clear),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat.mw-parser-output .id-lock-subscription a,.mw-parser-output .quotation .cs1-lock-subscription abackground:linear-gradient(clear,clear),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em middle/9px no-repeat.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolour:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:assist.mw-parser-output .cs1-ws-icon abackground:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em heart/12px no-repeat.mw-parser-output code.cs1-codecolour:inherit;background:inherit;border:none;padding:inherit.mw-parser-output .cs1-hidden-errorshow:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-maintshow:none;color:#33aa33;margin-left:0.3em.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em.mw-parser-output .quotation .mw-selflinkfont-weight:inheritLaki Ok (December 1972). "Our ancient heritage in blood clotting and some of its consequences". Annals of the New York Academy of Sciences. 202 (1): 297–307. Bibcode:1972NYASA.202..297L. doi:10.1111/j.1749-6632.1972.tb16342.x. PMID 4508929. ^ Machlus KR, Thon JN, Italiano JE (April 2014). "Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation". British Journal of Haematology. 165 (2): 227–36. doi:10.1111/bjh.12758. PMID 24499183. ^ Jain NC (June 1975). "A scanning electron microscopic study of platelets of certain animal species". Thrombosis et Diathesis Haemorrhagica. 33 (3): 501–7. PMID 1154309. ^ a b c d e f g Michelson, Alan D. (2013). Platelets (3rd ed.). Academic. ISBN 9780123878373. ^ Paulus JM (September 1975). "Platelet size in man". Blood. 46 (3): 321–36. doi:10.1182/blood.V46.3.321.321. PMID 1097000. ^ a b c d e Yip J, Shen Y, Berndt MC, Andrews RK (February 2005). "Primary platelet adhesion receptors". IUBMB Life. 57 (2): 103–8. doi:10.1080/15216540500078962. PMID 16036569. ^ Berridge, Michael J. (1 October 2014). "Module 11: Cell Stress, Inflammatory Responses and Cell Death". Cell Signalling Biology. 6: csb0001011. doi:10.1042/csb0001011. ^ a b c d Gaertner F, Massberg S (December 2016). "Blood coagulation in immunothrombosis-At the frontline of intravascular immunity". Seminars in Immunology. 28 (6): 561–569. doi:10.1016/j.smim.2016.10.010. PMID 27866916. ^ Hampton T (April 2018). "Platelets' Role in Adaptive Immunity May Contribute to Sepsis and Shock". JAMA. 319 (13): 1311–1312. doi:10.1001/jama.2017.12859. PMID 29614158. ^ Girling JH (July 1962). "An automatic platelet counting technique". The Journal of Medical Laboratory Technology. 19: 168–73. PMID 13898919. ^ Ross DW, Ayscue LH, Watson J, Bentley SA (September 1988). "Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation". American Journal of Clinical Pathology. 90 (3): 262–7. doi:10.1093/ajcp/90.3.262. PMID 3414599. ^ Ruocco L, Del Corso L, Romanelli AM, Deri D, Pentimone F (April 2001). "New hematological indices in the healthy elderly". Minerva Medica. 92 (2): 69–73. PMID 11323567. ^ Lozano M, Narváez J, Faúndez A, Mazzara R, Cid J, Jou JM, Marín JL, Ordinas A (June 1998). "[Platelet count and mean platelet volume in the Spanish population]". Medicina Clinica. 110 (20): 774–7. PMID 9666418. ^ Frojmovic MM (1976). "Geometry of normal mammalian platelets by quantitative microscopic studies". Biophysical Journal. 16 (9): 1071–1089. doi:10.1016/s0006-3495(76)85756-6. PMC 1334946. PMID 786400. ^ Moskalensky AE, Yurkin MA, Konokhova AI, Strokotov DI, Nekrasov VM, Chernyshev AV, Tsvetovskaya GA, Chikova ED, Maltsev VP (2013). "Accurate measurement of volume and shape of resting and activated blood platelets from light scattering". Journal of Biomedical Optics. 18 (1): 017001. doi:10.1117/1.JBO.18.1.017001. PMID 23288415. S2CID 44626047. ^ Moskalensky AE, Yurkin MA, Muliukov AR, Litvinenko AL, Nekrasov VM, Chernyshev AV, Maltsev VP (2018). "Method for the simulation of blood platelet shape and its evolution during activation". PLOS Computational Biology. 14 (3): e1005899. doi:10.1371/journal.pcbi.1005899. PMC 5860797. PMID 29518073. ^ Harker LA, Roskos LK, Marzec UM, Carter RA, Cherry JK, Sundell B, Cheung EN, Terry D, Sheridan W (April 2000). "Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers". Blood. 95 (8): 2514–22. doi:10.1182/blood.V95.8.2514. PMID 10753829. ^ Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, Huang DC, Kile BT (March 2007). "Programmed anuclear cell death delimits platelet life span". Cell. 128 (6): 1173–86. doi:10.1016/j.cellular.2007.01.037. PMID 17382885. S2CID 7492885. ^ Palmer RM, Ferrige AG, Moncada S (1987). "Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor". Nature. 327 (6122): 524–6. Bibcode:1987Natur.327..524P. doi:10.1038/327524a0. PMID 3495737. S2CID 4305207. ^ Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE (2012). "Endogenous inhibitory mechanisms and the regulation of platelet function". Platelets and Megakaryocytes. Methods in Molecular Biology. 788. pp. 341–66. doi:10.1007/978-1-61779-307-3_23. ISBN 978-1-61779-306-6. PMID 22130718. ^ Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R (April 2005). "Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection". Seminars in Thrombosis and Hemostasis. 31 (2): 234–46. doi:10.1055/s-2005-869528. PMID 15852226. ^ Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC (May 2006). "Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo". Blood. 107 (10): 3902–6. doi:10.1182/blood-2005-09-3687. PMC 1895285. PMID 16455953. ^ Litvinov RI, Weisel JW, Andrianova IA, Peshkova AD, Minh GL (2018). "Differential Sensitivity of Various Markers of Platelet Activation with Adenosine Diphosphate". BioNanoScience. 9 (1): 53–58. doi:10.1007/s12668-018-0586-4. PMC 6750022. PMID 31534882. ^ Matarrese P, Straface E, Palumbo G, Anselmi M, Gambardella L, Ascione B, Del Principe D, Malorni W (February 2009). "Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A--activation and long-term commitment to cell death". The FEBS Journal. 276 (3): 845–56. doi:10.1111/j.1742-4658.2008.06829.x. PMID 19143843. ^ White JG (December 1987). "An overview of platelet structural physiology". Scanning Microsc. 1 (4): 1677–700. PMID 3324323. ^ Behnke O (1970). "The morphology of blood platelet membrane systems". Series Haematologica. 3 (4): 3–16. PMID 4107203. ^ a b Bouchard BA, Mann KG, Butenas S (August 2010). "No evidence for tissue factor on platelets". Blood. 116 (5): 854–5. doi:10.1182/blood-2010-05-285627. PMC 2918337. PMID 20688968. ^ Ahmad SS, Rawala-Sheikh R, Walsh PN (1992). "Components and assembly of the factor X activating complex". Seminars in Thrombosis and Hemostasis. 18 (3): 311–23. doi:10.1055/s-2007-1002570. PMID 1455249. ^ Tyagi T, Ahmad S, Gupta N, Sahu A, Ahmad Y, Nair V, Chatterjee T, Bajaj N, Sengupta S, Ganju L, Singh SB, Ashraf MZ (February 2014). "Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype". Blood. 123 (8): 1250–60. doi:10.1182/blood-2013-05-501924. PMID 24297866. ^ O'Halloran AM, Curtin R, O'Connor F, Dooley M, Fitzgerald A, O'Brien JK, Fitzgerald DJ, Shields DC (February 2006). "The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets". British Journal of Haematology. 132 (4): 494–502. doi:10.1111/j.1365-2141.2005.05897.x. PMID 16412022. ^ Coller BS, Cheresh DA, Asch E, Seligsohn U (January 1991). "Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel". Blood. 77 (1): 75–83. doi:10.1182/blood.V77.1.75.75. PMID 1702031. ^ Nguyen, D.T., Orgill D.P., Murphy G.F. (2009). Chapter 4: The Pathophysiologic Basis for Wound Healing and Cutaneous Regeneration. Biomaterials For Treating Skin Loss. Woodhead Publishing (UK/Europe) & CRC Press (US), Cambridge/Boca Raton, pp. 25–57. (ISBN 978-1-4200-9989-Eight ISBN 978-1-84569-363-3) ^ Movat HZ, Weiser WJ, Glynn MF, Mustard JF (December 1965). "Platelet phagocytosis and aggregation". The Journal of Cell Biology. 27 (3): 531–43. doi:10.1083/jcb.27.3.531. PMC 2106759. PMID 4957257. ^ a b c Jenne CN, Urrutia R, Kubes P (June 2013). "Platelets: bridging hemostasis, inflammation, and immunity". International Journal of Laboratory Hematology. 35 (3): 254–61. doi:10.1111/ijlh.12084. PMID 23590652. ^ Levin J (2007), "The Evolution of Mammalian Platelets", Platelets, Elsevier, pp. 3–22, doi:10.1016/b978-012369367-9/50763-1, ISBN 9780123693679 ^ Cox D, Kerrigan SW, Watson SP (June 2011). "Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation". Journal of Thrombosis and Haemostasis. 9 (6): 1097–107. doi:10.1111/j.1538-7836.2011.04264.x. PMID 21435167. ^ Weyrich AS, Zimmerman GA (September 2004). "Platelets: signaling cells in the immune continuum". Trends in Immunology. 25 (9): 489–95. doi:10.1016/j.it.2004.07.003. PMID 15324742. ^ Wagner DD, Burger PC (December 2003). "Platelets in inflammation and thrombosis". Arteriosclerosis, Thrombosis, and Vascular Biology. 23 (12): 2131–7. doi:10.1161/01.ATV.0000095974.95122.EC. PMID 14500287. ^ Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH (July 1996). "Platelet-mediated lymphocyte delivery to high endothelial venules". Science. 273 (5272): 252–5. Bibcode:1996Sci...273..252D. doi:10.1126/science.273.5272.252. PMID 8662511. S2CID 21334521. ^ Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Chisari FV, Ruggeri ZM, Guidotti LG (November 2005). "Platelets mediate cytotoxic T lymphocyte-induced liver damage". Nature Medicine. 11 (11): 1167–9. doi:10.1038/nm1317. PMC 2908083. PMID 16258538. ^ Oehlers, Stefan H.; Tobin, David M.; Britton, Warwick J.; Shavit, Jordan A.; Nguyen, Tuong; Johansen, Matt D.; Johnson, Khelsey E.; Hortle, Elinor (2019). "Thrombocyte inhibition restores protective immunity to mycobacterial infection in zebrafish". The Journal of Infectious Diseases. 220 (3): 524–534. doi:10.1093/infdis/jiz110. PMC 6603966. PMID 30877311. ^ Gaertner F, Ahmad Z, Rosenberger G, Fan S, Nicolai L, Busch B, Yavuz G, Luckner M, Ishikawa-Ankerhold H, Hennel R, Benechet A, Lorenz M, Chandraratne S, Schubert I, Helmer S, Striednig B, Stark K, Janko M, Böttcher RT, Verschoor A, Leon C, Gachet C, Gudermann T, Mederos Y, Schnitzler M, Pincus Z, Iannacone M, Haas R, Wanner G, Lauber Okay, Sixt M, Massberg S (November 2017). "Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria". Cell. 171 (6): 1368–1382.e23. doi:10.1016/j.cellular.2017.11.001. PMID 29195076. ^ Boilard E, Nigrovic PA, Larabee Okay, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM (January 2010). "Platelets amplify inflammation in arthritis via collagen-dependent microparticle production". Science. 327 (5965): 580–3. Bibcode:2010Sci...327..580B. doi:10.1126/science.1181928. PMC 2927861. PMID 20110505. ^ a b Palankar R, Kohler TP, Krauel Ok, Wesche J, Hammerschmidt S, Greinacher A (June 2018). "Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA". Journal of Thrombosis and Haemostasis. 16 (6): 1187–1197. doi:10.1111/jth.13955. PMID 29350833. ^ McMorran BJ, Wieczorski L, Drysdale KE, Chan JA, Huang HM, Smith C, Mitiku C, Beeson JG, Burgio G, Foote SJ (December 2012). "Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum". Science. 338 (6112): 1348–51. Bibcode:2012Sci...338.1348M. doi:10.1126/science.1228892. PMID 23224555. S2CID 206544569. ^ Murakawa M, Okamura T, Tsutsumi Okay, Tanoguchi S, Kamura T, Shibuya T, Harada M, Niho Y (1992). "Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment". Acta Haematologica. 87 (1–2): 83–7. doi:10.1159/000204725. PMID 1585777. ^ van Genderen PJ, Leenknegt H, Michiels JJ, Budde U (September 1996). "Acquired von Willebrand disease in myeloproliferative disorders". Leukemia & Lymphoma. 22 Suppl 1: 79–82. doi:10.3109/10428199609074364. PMID 8951776. ^ Jiang, L.; Xu, C.; Yu, S.; Liu, P.; Luo, D.; Zhou, Q.; Gao, C.; Hu, H. (2013). "A critical role of thrombin/PAR-1 in ADP-induced platelet secretion and the second wave of aggregation". Journal of Thrombosis and Haemostasis. 11 (5): 930–940. doi:10.1111/jth.12168. ISSN 1538-7933. ^ Lind, Stuart E.; Kurkjian, Carla D. (2011). "The bleeding time". In Michelson, Alan D. (ed.). Platelets (2d ed.). Elsevier. p. 485. ISBN 9780080465869. ^ Duke WW (1910). "The relation of blood platelets to hemorrhagic disease". JAMA. 55 (14): 1185–92. doi:10.1001/jama.1910.04330140029009. ^ a b c d e Borhany, Munira; Pahore, Zaen; ul Qadr, Zeeshan; Rehan, Muhammad; Naz, Arshi; Khan, Asif; Ansari, Saqib; Farzana, Tasneem; Nadeem, Muhammad; Raza, Syed Amir; Shamsi, Tahir (2010). "Bleeding disorders in the tribe: result of consanguineous in breeding". Orphanet Journal of Rare Diseases. 5 (1). doi:10.1186/1750-1172-5-23. ISSN 1750-1172. ^ a b "Why Perform Platelet Aggregation?". Helena Biosciences. 2015 ^ Cuker, Adam (2014). "Light Transmission Aggregometry". The Hematologist. 11 (2). doi:10.1182/hem.V11.2.2555. ISSN 1551-8779. ^ "Platelet Function Assay FAQ" (PDF). Department of Pathology. Virginia Commonwealth University. Retrieved 2017-03-27. ^ Geddis AE (February 2013). "Inherited thrombocytopenias: an approach to diagnosis and management". International Journal of Laboratory Hematology. 35 (1): 14–25. doi:10.1111/j.1751-553x.2012.01454.x. PMID 22846067. ^ Cure MC, Cure E, Kirbas A, Cicek AC, Yuce S (July 2013). "The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters". Blood Coagulation & Fibrinolysis. 24 (5): 484–8. doi:10.1097/MBC.0b013e32835e4230. PMID 23348429. S2CID 31284130. ^ Kornerup KN, Page CP (August 2007). "The role of platelets in the pathophysiology of asthma". Platelets. 18 (5): 319–28. doi:10.1080/09537100701230436. PMID 17654302. S2CID 7923694. ^ Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, Castells MC, Chhay H, Boyce JA (April 2012). "Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes". Blood. 119 (16): 3790–8. doi:10.1182/blood-2011-10-384826. PMC 3335383. PMID 22262771. ^ Erpenbeck L, Schön MP (April 2010). "Deadly allies: the fatal interplay between platelets and metastasizing cancer cells". Blood. 115 (17): 3427–36. doi:10.1182/blood-2009-10-247296. PMC 2867258. PMID 20194899. ^ Pleass RJ (July 2009). "Platelet power: sticky problems for sticky parasites?". Trends in Parasitology. 25 (7): 296–9. doi:10.1016/j.pt.2009.04.002. PMC 3116138. PMID 19539528. ^ "Summaries for patients. Platelet function after taking Ibuprofen for 1 week". Annals of Internal Medicine. 142 (7): I–54. April 2005. doi:10.7326/0003-4819-142-7-200504050-00004. PMID 15809457. ^ Rao GH, Johnson GG, Reddy KR, White JG (1983). "Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin". Arteriosclerosis. 3 (4): 383–8. doi:10.1161/01.ATV.3.4.383. PMID 6411052. S2CID 3229482. ^ van Veen JJ, Nokes TJ, Makris M (January 2010). "The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals". British Journal of Haematology. 148 (1): 15–25. doi:10.1111/j.1365-2141.2009.07899.x. PMID 19775301. ^ Roback J, Grossman B, Harris T, Hillyer C, eds. (2011). Technical Manual (17th ed.). Bethesda MD: AABB. p. 580. ISBN 978-1-56395-315-6. ^ American Association of Blood Banks (2003). "5.1.5.1". Standards for Blood Banks and Transfusion Services (22nd ed.). Bethesda MD: AABB. ^ Högman CF (January 1992). "New trends in the preparation and storage of platelets". Transfusion. 32 (1): 3–6. doi:10.1046/j.1537-2995.1992.32192116428.x. PMID 1731433. ^ Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (June 2004). "Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light". Transfusion. 44 (6): 877–85. doi:10.1111/j.1537-2995.2004.03355.x. PMID 15157255. ^ Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G (June 2005). "Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates". Transfusion. 45 (6): 911–9. doi:10.1111/j.1537-2995.2005.04350.x. PMID 15934989. ^ Prowse CV (April 2013). "Component pathogen inactivation: a critical review". Vox Sanguinis. 104 (3): 183–99. doi:10.1111/j.1423-0410.2012.01662.x. PMID 23134556. ^ AABB (2009). Standards for Blood Banks and Transfusion Services (twenty sixth ed.). Bethesda MD: AABB. ^ Schoenfeld H, Spies C, Jakob C (March 2006). "Volume-reduced platelet concentrates". Current Hematology Reports. 5 (1): 82–8. PMID 16537051. ^ CBBS: Washed and volume-reduced Plateletpheresis units Archived 2014-04-14 at the Wayback Machine. Cbbsweb.org (2001-10-25). Retrieved on 2011-11-14. ^ Gawaz M, Vogel S (October 2013). "Platelets in tissue repair: control of apoptosis and interactions with regenerative cells". Blood. 122 (15): 2550–4. doi:10.1182/blood-2013-05-468694. PMID 23963043. ^ Schmaier AA, Stalker TJ, Runge JJ, Lee D, Nagaswami C, Mericko P, Chen M, Cliché S, Gariépy C, Brass LF, Hammer DA, Weisel JW, Rosenthal Ok, Kahn ML (September 2011). "Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease". Blood. 118 (13): 3661–9. doi:10.1182/blood-2011-02-338244. PMC 3186337. PMID 21816834. ^ Belamarich FA, Shepro D, Kien M (November 1968). "ADP is not involved in thrombin-induced aggregation of thrombocytes of a non-mammalian vertebrate". Nature. 220 (5166): 509–10. Bibcode:1968Natur.220..509B. doi:10.1038/220509a0. PMID 5686175. S2CID 4269208. ^ Lancet, 1882, ii. 916; Notes of Gulliver's Researches in Anatomy, Physiology, Pathology, and Botany, 1880; Carpenter's Physiology, ed. Power, ninth ed., see Index underneath 'Gulliver.' ^ Godlee, Sir Rickman (1917). Lord Lister. London: Macmillan & Co. ^ Robb-Smith AH (July 1967). "Why the platelets were discovered". British Journal of Haematology. 13 (4): 618–37. doi:10.1111/j.1365-2141.1967.tb00769.x. PMID 6029960. ^ Beale LS (1864). "On the Germinal Matter of the Blood, with Remarks upon the Formation of Fibrin". Transactions of the Microscopical Society & Journal. 12: 47–63. doi:10.1111/j.1365-2818.1864.tb01625.x. ^ Schultze M (1865). "Ein heizbarer Objecttisch und seine Verwendung bei Untersuchungen des Blutes". Arch Mikrosk Anat. 1 (1): 1–42. doi:10.1007/BF02961404. S2CID 84919090. ^ Bizzozero, J. (1882). "Über einen neuen Forrnbestandteil des Blutes und dessen Rolle bei der Thrombose und Blutgerinnung". Arch Pathol Anat Phys Klin Med. 90 (2): 261–332. doi:10.1007/BF01931360. S2CID 37267098. ^ Brewer DB (May 2006). "Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet". British Journal of Haematology. 133 (3): 251–8. doi:10.1111/j.1365-2141.2006.06036.x. PMID 16643426. ^ Osler W (1886). "On certain problems in the physiology of the blood corpuscles". The Medical News. 48: 421–25. ^ Wright JH (1906). "The Origin and Nature of the Blood Plates". The Boston Medical and Surgical Journal. 154 (23): 643–45. doi:10.1056/NEJM190606071542301. ^ Wright JH (1910). "The histogenesis of blood platelets". Journal of Morphology. 21 (2): 263–78. doi:10.1002/jmor.1050210204. hdl:2027/hvd.32044107223588. ^ Furie B, Furie BC (August 2008). "Mechanisms of thrombus formation". The New England Journal of Medicine. 359 (9): 938–49. doi:10.1056/NEJMra0801082. PMID 18753650.

External links

Wikimedia Commons has media comparable to platelets.Video summarizing platelet dynamics ( Page will play audio when loaded)

vteMyeloid blood cells and plasmaHematopoiesisMyelopoiesis(CFU-GEMM)CFU-GM Granulopoiesis Myeloblast Promyelocyte Myelocyte Metamyelocyte Band mobile Monocytopoiesis Monoblast PromonocyteMEP Thrombopoiesis Megakaryoblast Promegakaryocyte Erythropoiesis Proerythroblast Normoblast ReticulocyteGeneral Extramedullary hematopoiesisMyeloid tissueGranulocytes Myeloblast Band cellular Neutrophil Basophil CFU-Baso Eosinophil CFU-Eos Mast cellular CFU-MastMonocytesMacrophages Histiocytes Kupffer cells Alveolar macrophage Microglia Osteoclasts Epithelioid cells large cells Langhans massive cells Foreign-body giant cellular Touton massive cellsOther Antigen-presenting cells Dendritic cells Langerhans mobile CFU-DL Monoblast MPSPlatelets CFU-Meg Megakaryoblast Promegakaryocyte MegakaryocyteRed blood cells Reticulocyte Nucleated crimson blood cellular CFU-EImmune response Leukocyte extravasation Phagocytosis Intrinsic immunityOther Precursor cells CFU-GM Megakaryocyte–erythroid progenitor mobile CFU-GEMM MyelomonocyteOther Phagocyte Plasma Hematopoietic machine Hematopoietic stem mobile vteProteins involved in coagulationCoagulation componentsPrimary hemostasis vWF platelet membrane glycoproteins: Ib (A B IX) IIb/IIIa (IIb IIIa) VIIntrinsic pathway HMWK/Bradykinin Prekallikrein/Kallikrein XII "Hageman" XI IX VIIIExtrinsic pathway III "Tissue factor" VIICommon pathway X V II "(Pro)thrombin" I "Fibrin" Fibrinogen (FGA, FGG) XIIICoagulation inhibitors Antithrombin (inhibits II, IX, X, XI, XII) Protein C (inhibits V, VIII)/Protein S (cofactor for protein C) Protein Z (inhibits X) ZPI (inhibits X, XI) TFPI (inhibits III)Thrombolysis/fibrinolysis Plasmin tPA/urokinase PAI-1/2 α2-AP α2-macroglobulin TAFI vteBlood transfusion and transfusion medicationBlood merchandise Whole blood Platelets Platelet transfusion Red blood cells Plasma Fresh frozen plasma PF24 Cryoprecipitate Cryosupernatant White blood cells Granulocyte transfusion Blood substitutesGeneral ideas Blood donation Methods Apheresis (plasmapheresis, plateletpheresis, leukapheresis) Exchange transfusion Intraoperative blood salvage Tests Blood compatibility trying out Cross-matching Coombs test Kleihauer–Betke check Blood bank International Society of Blood Transfusion ISBT 128Transfusion reactionsand opposed results Transfusion hemosiderosis Transfusion similar acute lung injury Transfusion associated circulatory overload Transfusion-associated graft versus host illness Febrile non-hemolytic transfusion reaction Hemolytic reaction acute delayed Serum illness Transfusion transmitted infectionBlood crew methods Blood types ABO Secretor status Augustine CD59 Chido-Rodgers Colton Cromer Diego Dombrock Duffy Er FORS Gerbich GIL GLOB Hh Ii Indian JR JMH KANNO Kell (Xk) Kidd Knops Lan Lewis Lutheran LW MNS OK P Raph Rh and RHAG Scianna Sid T-Tn Vel Xg Yt Other Authority regulate GND: 4059964-4 LCCN: sh85015006 MA: 89560881, 2909297776 NDL: 00565651 Retrieved from "https://en.wikipedia.org/w/index.php?title=Platelet&oldid=1016518781"